NCT05044572
- Conditions
- Central Nervous System Diseases, Dyskinesias, Movement Disorders, +4 more
- Locations
-
- Sarwat Anwar Medical Complex Hospital Lahore, Punjab Province, Pakistan
Clinical trial condition
Dyskinesias
Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.
123 public trials
15 recruiting studies
Dyskinesias trial results
NCT02611713
- Conditions
- Advanced Parkinson's Disease, Behavior, Behavioral Symptoms, +10 more
- Locations
-
- University of Alabama at Birmingham - Main /ID# 144422 Birmingham, Alabama, United States
- Parkinson's Disease and Moveme /ID# 144413 Boca Raton, Florida, United States
- University of Florida - Archer /ID# 144415 Gainesville, Florida, United States
- University of Miami /ID# 144420 Miami, Florida, United States
NCT02195700
- Conditions
- Central Nervous System Diseases, Dyskinesia, Drug-Induced, Dyskinesias, +6 more
- Locations
-
- Tuscaloosa, Alabama, United States
- Anaheim, California, United States
- Glendale, California, United States
- Oceanside, California, United States
NCT04083586
- Conditions
- Central Nervous System Diseases, Dyskinesias, Involuntary Movements, +5 more
- Locations
-
- AssiutU Asyut, Egypt
Completed
Foot Posture Index, Hallux Limitus in Patients With Chronic Low Back Pain. Gait With Optogait Sensor
NCT04607863
- Conditions
- Back Pain Lower Back Chronic, Central Nervous System Diseases, Dyskinesias, +14 more
- Locations
-
- Aurora Castro Mendez Seville, Spain
NCT00623363
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- The Parkinson's and Movement Disorder Institute Fountain Valley, California, United States
- University of South Florida, Parkinson's Disease and Movement Disorders Center Tampa, Florida, United States
- Emory University--Wesley Woods Health Center Atlanta, Georgia, United States
- UMDNJ-Robert Wood Johnson Medical School New Brunswick, New Jersey, United States
NCT04730245
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- Torre Medica Sante León, Guanajuato, Mexico
Completed
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
NCT01474421
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Novartis Investigative Site Sacramento, California, United States
- Novartis Investigative Site Manhasset, New York, United States
- Novartis Investigative Site Cincinnati, Ohio, United States
- Novartis Investigative Site Cleveland, Ohio, United States
NCT01491932
- Conditions
- Anti-Dyskinesia Agents, Basal Ganglia Diseases, Brain Diseases, +11 more
- Locations
-
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Kansas City, Kansas, United States
- Novartis Investigative Site Milwaukee, Wisconsin, United States
- Novartis Investigative Site Innsbruck, Austria
NCT01173731
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
- Locations
-
- Novartis Investigative Site Sunnyvale, California, United States
- Novartis Investigative Site Englewood, Colorado, United States
- Novartis Investigative Site Indianapolis, Indiana, United States
- Novartis Investigative Site Heidelberg, Victoria, Australia